Basile Paul-Petit

Basile Paul-Petit is a Private Equity Partner at Otium since 2023, where €200 million is invested annually in private, mature, and growing businesses through roll-up strategies and primary LBOs. Alongside this role, Basile serves as a Board Member for several companies, including Groupe Archipel, Otelium, Enosium Life Science, Comet Software, Atraltech, Alfeor, and Groupe NovaVet. Previously, Basile was the Head of Corporate Investment/M&A at COLISEE from 2021 to 2023, leading external growth strategies in the healthcare sector. Earlier roles include corporate investment/M&A at Danone from 2019 to 2021, focusing on acquisitions and partnerships across various global markets. Basile holds a Master's degree in Corporate Finance & Finance Engineering from Université Paris Dauphine - PSL and a Level II qualification from the Wine & Spirit Education Trust.